Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody. 1997

M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.

NNKY5-5, an IgG monoclonal antibody directed against the von Willebrand factor-binding domain of glycoprotein (GP) Ib alpha, induced weak but irreversible aggregation (or association) of platelets in citrate-anticoagulated platelet-rich plasma. This phenomenon was defined as small aggregate formation (SAF). Platelets in hirudin-anticoagulated plasma or washed platelets showed little response to NNKY5-5 alone, but the antibody potentiated aggregation induced by low concentrations of adenosine diphosphate or platelet-activating factor. NNKY5-5 did not induce granule release or intracellular Ca2+ mobilization. However, NNKY5-5 caused tyrosine phosphorylation of a 64-kD protein and activation of a tyrosine kinase, p72syk. An anti-Fc gamma II receptor antibody had no effect on SAF, suggesting that NNKY5-5 activated platelets by interacting with glycoprotein Ib. Fab' fragments of NNKY5-5 did not induce SAF, but potentiated aggregation induced by other agonists. The Fab' fragment of NNKY5-5 induced the activation of p72syk, suggesting that such activation was independent of the Fc gamma II receptor. Cross-linking of the receptor-bound Fab' fragment of NNKY5-5 with a secondary antibody induced SAF. GRGDS peptide, chelation of extracellular Ca2+, and an anti-GPIIb/IIIa antibody inhibited NNKY5-5-induced SAF, but had no effect on 64-kD protein tyrosine phosphorylation or p72syk activations. Various inhibitors, including aspirin and protein kinase C, had no effect on SAF, protein tyrosine phosphorylation, or p72syk activation. In contrast, tyrphostin 47, a potent tyrosine kinase inhibitor, inhibited NNKY5-5-induced SAF as well as tyrosine phosphorylation and p72syk activation. Our findings suggest that binding of NNKY5-5 to GPIb potentiates platelet aggregation by facilitating the interaction between fibrinogen and GPIIb/IIIa through a mechanism associated with p72syk activation and tyrosine phosphorylation of a 64-kD protein.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072377 Syk Kinase An SH2 domain-containing non-receptor tyrosine kinase that regulates signal transduction downstream of a variety of receptors including B-CELL ANTIGEN RECEPTORS. It functions in both INNATE IMMUNITY and ADAPTIVE IMMUNITY and also mediates signaling in CELL ADHESION; OSTEOGENESIS; PLATELET ACTIVATION; and vascular development. SYK Tyrosine Kinase,Spleen Tyrosine Kinase,Kinase, SYK Tyrosine,Kinase, Spleen Tyrosine,Kinase, Syk,Tyrosine Kinase, SYK,Tyrosine Kinase, Spleen
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
May 1987, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
August 1994, Molecular and cellular biology,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
June 1994, Proceedings of the National Academy of Sciences of the United States of America,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
January 1991, Arteriosclerosis and thrombosis : a journal of vascular biology,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
April 1996, Thrombosis and haemostasis,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
December 2005, Platelets,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
April 1996, Molecular and cellular biology,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
December 1988, Immunology letters,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
August 1993, The Journal of biological chemistry,
M Yanabu, and Y Ozaki, and S Nomura, and T Miyake, and Y Miyazaki, and H Kagawa, and Y Yamanaka, and N Asazuma, and K Satoh, and S Kume, and Y Komiyama, and S Fukuhara
April 1995, Biochimica et biophysica acta,
Copied contents to your clipboard!